Bio&Me
PrivateLast Round
VC Round
Nov 14, 2022
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bio&Me operates in Consumer & Commerce and is based in Chester. Its latest recorded funding round was a VC Round in November 2022.
Bio&Me is a food products company that produces prebiotic, gut-friendly, and plant-based food products intended to bring clarity and credibility to the world of gut health.
Sector
Consumer & Commerce
Verticals
D2C Brands, Home & Lifestyle, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bio&Me Comparables
Compare Bio&Me with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spoon Cereals | 86% | |
| Rollagranola | 83% | |
| Oddlygood Global | 80% |
For institutional investors. Book with your work email.
Bio&Me Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 14, 2022 | ||||
| VC Round | Mar 10, 2022 | ||||
| Angel | Feb 10, 2021 | ||||
| Debt | Apr 20, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
Grew 17% QoQ from 29 to 34 employees.
- Apr 3, 2026
FMCG veteran David Titman appointed to new CMO role.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 9, 2026
Bio&Me Limited. and Pip & Nut partner to launch co-branded peanut butter granola exclusively in 803 Tesco stores from Nov 16th '26.
- launchesNov 9, 2026
Bio&Me Limited. teams up with Pip & Nut to launch Peanut Butter Granola, a co-branded granola with nine plant-based foods, exclusively in 803 Tesco stores from Nov 16th '26.
- receives_awardAug 28, 2026
Bio&Me Limited. receives two Grocer Gold Awards for exceptional business growth, innovation and leadership in the United Kingdom on Aug 28th '26.
- recognized_asAug 28, 2026
In Aug '26, Bio&Me Limited. earns recognition from The Sunday Times as the 60th-ranked company in its 100 Fastest-Growing Private Companies list, alongside two Grocer Gold Awards and three Great Taste Awards in United Kingdom.
- receives_awardAug 28, 2026
Bio&Me Limited. receives three Great Taste Awards in Chester on Aug 28th '26 for products including Vanilla Kefir Yoghurt, Mango and Peach Kefir Drink, and Vanilla Matcha Kefir Drink.
For institutional investors. Book with your work email.
Bio&Me Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bio&Me's valuation, stock price, and market status.
Is Bio&Me a public or private company?
Bio&Me is a private company.
What is the current stock price of Bio&Me?
Bio&Me is a private company, so its shares have no public market price. Caplight tracks Bio&Me's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bio&Me worth (valuation)?
Valuation information for Bio&Me is not publicly available.
Can I buy Bio&Me stock?
Bio&Me shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bio&Me's last funding round?
Bio&Me's most recent funding round was VC Round on November 14, 2022.
Who are the main investors in Bio&Me?
Investor information for Bio&Me is not publicly disclosed.
Will Bio&Me IPO soon?
No public IPO plans have been announced for Bio&Me.
How can I track Bio&Me secondary market activity?
Caplight tracks bids, offers, and trades in Bio&Me's shares on secondary markets.